DCF — CPMC-R.K. DAVIES MEDICAL CENTER
Enterprise Value: $155.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$155.3M
Enterprise Value
$39.5M
PV of Cash Flows
$115.8M
PV of Terminal Value
$186.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $251.0M | $21.3M | 9.0% | $6.9M | $6.3M |
| Year 2 | $258.5M | $24.6M | 10.0% | $9.1M | $7.5M |
| Year 3 | $266.2M | $28.0M | 11.0% | $11.4M | $8.5M |
| Year 4 | $274.2M | $30.2M | 11.0% | $12.7M | $8.7M |
| Year 5 | $282.5M | $31.8M | 11.0% | $13.6M | $8.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $155.3M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$243.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000065666249
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5